Oral Anticoagulant Treatment and the Risk of Dementia in Patients With Atrial Fibrillation: A Population‐Based Cohort Study

Oral Anticoagulant Treatment and the Risk of Dementia in Patients With Atrial Fibrillation: A Population‐Based Cohort Study

Background We compared the dementia incidence rate between users and nonusers of oral anticoagulants (OACs) in a large cohort of primary care patients with atrial fibrillation. Methods and Results We performed a retrospective study using an Australia‐wide primary care data set, MedicineInsight. Pati...

Full description

Bibliographic Details
Main Authors: Woldesellassie M. Bezabhe, Luke R. Bereznicki, Jan Radford, Barbara C. Wimmer, Mohammed S. Salahudeen, Edward Garrahy, Ivan Bindoff, Gregory M. Peterson
Format: Article
Language:English
Published: Wiley 2022-04-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
atrial fibrillation
dementia
direct‐acting oral anticoagulants
oral anticoagulants
warfarin
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.023098

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.121.023098

Similar Items